8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
METLIFE INC (MET)

MetLife ($MET) filed an 8‑K (Item 9.01) on Jan 9, 2026 furnishing a Historical Results Financial…

Filed with the SEC on · Summarized by InvestorsBot

MetLife ($MET) filed an 8‑K (Item 9.01) on Jan 9, 2026 furnishing a Historical Results Financial Supplement (Ex. 99.1) for quarters ended 12/31/2024, 3/31/2025, 6/30/2025, 9/30/2025 and year ended 12/31/2024. 📄📊 #SECfiling #FinReports

Exhibits: 99.1 (historical results), 101 (cover page formatted in Inline XBRL per Reg S‑T Rule 406), 104 (cover page interactive data embedded). Interactive XBRL included. 🧾 $MET #XBRL #Accounting

Report signed Jan 9, 2026 by Adrienne O'Neill, Executive VP & Chief Accounting Officer. Filed supplement provides historical quarterly and year‑end data for investor review. 🔎 $MET #MetLife #Investing

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from METLIFE INC

MetLife ($MET) confirmed declaration of a Q1 2026 dividend on its floating-rate, non‑cumulative preferred…

8-K · March 5, 2026

MetLife (Mar 5, 2026) confirms first quarter 2026 dividend of $0.31501229 per share on its floating-rate,…

8-K · March 5, 2026

METLIFE filed Underwriting & Pricing Agreements dated Feb 24, 2026 with lead bookrunners Barclays, BofA,…

8-K · February 26, 2026

MetLife ($MET) on Feb 24, 2026 entered underwriting and pricing agreements for sale of debentures with…

8-K · February 26, 2026

MetLife issued $1,000,000,000 of 5.850% Fixed‑to‑Fixed Reset Rate Subordinated Debentures due 2056 on Feb…

8-K · February 26, 2026

MetLife ($MET) Board increased directors from 11 to 13 and on Feb 24, 2026 elected Daniel S.

8-K · February 24, 2026